Literature DB >> 28721947

Removal of scatter radiation in paediatric cardiac catheterisation: a randomised controlled clinical trial.

Richard Gould1, Sonyia L McFadden, Andrew J Sands, Brian A McCrossan, Simon Horn, Kevin M Prise, Philip Doyle, Ciara M Hughes.   

Abstract

OBJECTIVE: This study sought to determine if DNA integrity was compromised by ionising radiation from paediatric cardiac catheterisations and if dose optimisation techniques allowed DNA integrity to be maintained.
MATERIALS AND METHODS: Children were imaged using either: (i) an anti-scatter grid (current departmental protocol), (ii) no anti-scatter grid or, (iii) no anti-scatter grid and a 15 cm air-gap between the child and the x-ray detector. Dose area product and image quality were assessed, lifetime attributable cancer risk estimates were calculated and DNA double-strand breakages quantified using the γH2AX assay.
RESULTS: Consent was obtained from 70 parents/guardians/children. Image quality was sufficient for each procedure performed. Removal of the anti-scatter grid resulted in dose reductions of 20% (no anti-scatter grid) and 30% (15 cm air-gap), DNA double-strand break reductions of 30% (no anti-scatter grid) and 20% (15 cm air-gap) and a reduction of radiation-induced cancer mortality risk of up to 45%.
CONCLUSION: Radiation doses received during paediatric cardiac catheterisation procedures resulted in a significant increase in DNA damage while maintaining acceptable image quality and diagnostic efficacy. It is feasible to remove the anti-scatter grid resulting in a reduction in DNA damage to the patient. The γH2AX assay may be used for assessment of dose optimisation strategies in children.

Entities:  

Mesh:

Year:  2017        PMID: 28721947     DOI: 10.1088/1361-6498/aa80a4

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  1 in total

1.  Estimating radiation exposure during paediatric cardiac catheterisation: a potential for radiation reduction with air gap technique.

Authors:  Reid C Chamberlain; Alexis C Shindhelm; Chu Wang; Gregory A Fleming; Kevin D Hill
Journal:  Cardiol Young       Date:  2019-11-04       Impact factor: 1.093

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.